Clinical Guides
Vitamin D Deficiency
An India-adapted, clinically focused guide to recognising vitamin D deficiency, confirming clinically meaningful disease, replacing safely and avoiding toxicity, with explicit calcium, renal, granulomatous disease, pregnancy and paediatric safeguards.
MedNext Academy | 19 min read
Vitamin D Deficiency
An India-adapted, clinically focused guide to recognising vitamin D deficiency, confirming clinically meaningful disease, replacing safely and avoiding toxicity, with explicit calcium, renal, granulomatous disease, pregnancy and paediatric safeguards.
Summary
Vitamin D is a fat-soluble vitamin (technically a prohormone) essential for CALCIUM HOMEOSTASIS and BONE HEALTH. Its deficiency causes rickets in children and osteomalacia in adults, and contributes to osteoporosis, muscle weakness, and falls.
**Vitamin D metabolism:** - Skin synthesis: UVB sunlight converts 7-dehydrocholesterol → cholecalciferol (vitamin D3). This is the MAJOR source (80-90% of vitamin D in sun-exposed populations). Requires direct UVB exposure (not through glass, not with sunscreen) - Dietary sources: Oily fish (salmon, mackerel, sardines), egg yolk, fortified foods (milk, cereals). Mushrooms exposed to sunlight provide vitamin D2. Dietary sources alone are RARELY sufficient - Liver: 25-hydroxylation → 25-hydroxyvitamin D [25(OH)D] (calcidiol). This is the storage form — measured to assess vitamin D status - Kidney: 1α-hydroxylation → 1,25-dihydroxyvitamin D [1,25(OH)₂D] (calcitriol). This is the ACTIVE form. Tightly regulated by PTH, calcium, and phosphate. NOT used for routine measurement of vitamin D status
**Functions of vitamin D:** - **Calcium absorption**: Vitamin D increases intestinal calcium absorption from ~10-15% (without vitamin D) to ~30-40% (with adequate vitamin D). Without vitamin D, you CANNOT absorb enough calcium from diet — regardless of how much calcium you eat - **Bone mineralisation**: Provides calcium and phosphate for hydroxyapatite crystal formation in bone. Deficiency → inadequate mineralisation → soft bones (rickets/osteomalacia) - **Phosphate homeostasis**: Increases intestinal phosphate absorption and renal phosphate reabsorption - **Muscle function**: Vitamin D receptors are present in skeletal muscle. Deficiency → proximal muscle weakness, increased falls risk - **Immune modulation**: Vitamin D modulates both innate and adaptive immunity. Deficiency is associated with increased susceptibility to respiratory infections, autoimmune conditions, and possibly TB susceptibility
**Vitamin D status classification:**
| Status | 25(OH)D Level | Clinical Significance | |--------|--------------|----------------------| | Deficient | <25 nmol/L (<10 ng/mL) | HIGH risk of rickets/osteomalacia | | Insufficient | 25-50 nmol/L (10-20 ng/mL) | Suboptimal bone health | | Sufficient | 50-125 nmol/L (20-50 ng/mL) | Adequate for bone health | | Possible excess | >125 nmol/L (>50 ng/mL) | Risk of hypercalcaemia at very high levels |
**Causes of deficiency:** - INADEQUATE SUNLIGHT: The most common cause globally and in India. Indoor lifestyle, office work, full-body clothing, sunscreen use, high-rise apartments with limited sun exposure, dark skin pigmentation (melanin reduces UVB penetration — darker-skinned individuals need MORE sun exposure) - DIETARY INSUFFICIENCY: Very few natural foods are rich in vitamin D. No significant fortification programme in India (unlike the US/UK where milk and cereals are fortified) - MALABSORPTION: Coeliac disease, inflammatory bowel disease, pancreatic insufficiency, post-bariatric surgery - INCREASED METABOLISM: Anti-epileptic drugs (phenytoin, carbamazepine, phenobarbitone), rifampicin — all induce CYP3A4, accelerating vitamin D metabolism - REDUCED SYNTHESIS: CKD (impaired 1α-hydroxylation), liver disease (impaired 25-hydroxylation) - OBESITY: Vitamin D is sequestered in adipose tissue, reducing bioavailability. Obese individuals need HIGHER doses
How Common Is It?
- Vitamin D deficiency is a GLOBAL PANDEMIC — an estimated 1 BILLION people worldwide have insufficient vitamin D
- Prevalence varies by latitude, skin pigmentation, clothing, diet, and indoor lifestyle
In India: - India has one of the HIGHEST rates of vitamin D deficiency in the world — despite being a TROPICAL country with abundant sunlight. This paradox is one of the most striking findings in Indian nutrition research - Prevalence: Multiple studies report vitamin D deficiency (25(OH)D <20 ng/mL) in 70-90% of the Indian population across all age groups, socioeconomic strata, and geographic regions. Even in sunny southern India, deficiency rates exceed 70% - WHY IS VITAMIN D DEFICIENCY SO COMMON IN INDIA? 1. **SKIN PIGMENTATION**: Indians have higher melanin content, which reduces UVB-mediated vitamin D synthesis by 50-70%. An Indian person needs 3-5 times more sun exposure than a fair-skinned person to produce the same amount of vitamin D 2. **INDOOR LIFESTYLE**: Urbanisation has moved Indians indoors. Office workers, students, homemakers, and increasingly children (screen time) spend most daylight hours inside. High-rise apartments, covered markets, and air-conditioned malls further reduce sun exposure 3. **CLOTHING**: Cultural and religious practices of full-body covering (especially among women — sari/salwar with dupatta covering head and arms, hijab/niqab/burqa) significantly reduce skin exposure to sunlight 4. **AIR POLLUTION**: India's severe urban air pollution (particularly particulate matter PM2.5) FILTERS UVB radiation. Studies from Delhi show that vitamin D synthesis is significantly impaired during pollution peaks (October-February — which is already the low-UVB season) 5. **VEGETARIAN DIET**: A large proportion of Indians are vegetarian. The richest dietary sources of vitamin D are oily fish (which vegetarians don't eat) and egg yolk (which many vegetarians also avoid). There is NO mandatory vitamin D fortification of milk or cereals in India 6. **LACK OF FORTIFICATION**: Unlike the US, UK, and Canada, India has NO national food fortification programme for vitamin D. FSSAI guidelines exist but implementation is voluntary and limited - HIGH-RISK GROUPS: Pregnant and lactating women (75-95% deficient in Indian studies), exclusively breastfed infants (breast milk contains very little vitamin D — 20-40 IU/L), elderly (reduced skin synthesis, less outdoor activity, reduced renal 1α-hydroxylation), post-menopausal women (compounding osteoporosis risk), dark-skinned individuals, those in purdah/full-body covering, obese individuals, CKD patients
Risk Factors
Risk is shaped by reduced cutaneous synthesis, low intake, impaired absorption or altered metabolism rather than by a laboratory number alone. Indoor work or schooling, limited outdoor time, air pollution, darker skin pigmentation, extensive clothing, sunscreen use and living in settings with little direct midday ultraviolet-B exposure can reduce synthesis. In India, these factors can coexist with vegetarian or vegan diets and limited reliable food fortification. Infants who are exclusively breastfed, older adults, people with obesity, housebound patients and those with little sun exposure deserve a careful dietary and social history rather than assumptions based on climate.
Malabsorption from coeliac disease, inflammatory bowel disease, pancreatic insufficiency, cholestatic liver disease or bariatric surgery can cause deficiency or failure to respond. Chronic liver or kidney disease can impair activation, but activated analogues are not routine substitutes for nutritional vitamin D. Phenytoin, carbamazepine, phenobarbital, rifampicin, glucocorticoids and some antiretroviral regimens may increase catabolism or alter bone risk. Ask about non-prescription sachets, injections, multivitamins and calcium products because duplicate dosing is common. Granulomatous disorders such as sarcoidosis and tuberculosis, lymphoma, primary hyperparathyroidism, hypercalciuria and renal stones make unsupervised supplementation unsafe. Pregnancy, lactation, infancy and chronic kidney disease require clinician-led dosing and monitoring.
Diagnosis
History
Ask about onset, duration, progression, relevant exposures, medicines, family history, pregnancy or breastfeeding, prior self-treatment and the effect on daily life. Clarify symptoms that change urgency and record what has already been tried, including dose, duration, adherence and adverse effects.
Examination
**In CHILDREN — Rickets:** - DELAYED MOTOR MILESTONES: Late sitting, delayed walking, difficulty climbing stairs - SKELETAL DEFORMITIES: Bowed legs (genu varum) or knock knees (genu valgum), wrist widening (rachitic rosary), frontal bossing of the skull, craniotabes (softening of the skull — press and feel 'ping-pong ball' give), Harrison's sulcus (groove at the lower rib margin from diaphragmatic pull on soft ribs) - DENTAL: Delayed eruption, enamel hypoplasia, dental caries - GROWTH RETARDATION: Poor linear growth - HYPOCALCAEMIC SEIZURES: In severe cases — particularly in neonates and infants. A MEDICAL EMERGENCY - Tetany: Carpopedal spasm, Trousseau's sign (carpal spasm with BP cuff inflation), Chvostek's sign (facial twitch on tapping)
**In ADULTS — Osteomalacia:** - BONE PAIN: Diffuse, dull aching bone pain — pelvis, lower back, ribs, shins. Often bilateral and symmetrical. Worsened by weight-bearing. Frequently misdiagnosed as 'fibromyalgia', 'chronic fatigue', 'non-specific body pains' (especially in India where 'body pain' is an extremely common presenting complaint) - PROXIMAL MUSCLE WEAKNESS: Difficulty climbing stairs, rising from a chair (waddling gait), combing hair. Often attributed to 'deconditioning' or 'ageing' - FATIGUE: Generalised tiredness — one of the commonest presenting symptoms, but also the most non-specific - FRACTURES: Pathological fractures with minimal trauma (insufficiency fractures). Looser's zones (pseudofractures — pathognomonic of osteomalacia) on X-ray: bilateral, symmetrical, ribbon-like lucencies perpendicular to the cortex — femoral neck, pelvis, ribs, scapula
Investigations
- **Serum 25-hydroxyvitamin D [25(OH)D]**: The DEFINITIVE test for vitamin D status. Measures the storage/circulating form. Deficient: <25 nmol/L (<10 ng/mL). Insufficient: 25-50 nmol/L (10-20 ng/mL). Sufficient: >50 nmol/L (>20 ng/mL). Widely available in India (₹800-2000)
- **Serum calcium**: May be LOW (hypocalcaemia) or NORMAL (if PTH compensation is adequate)
- **Serum phosphate**: May be LOW (hypophosphataemia) — vitamin D is needed for phosphate absorption and reabsorption
- **Alkaline phosphatase (ALP)**: ELEVATED — a marker of increased bone turnover (osteoblastic activity trying to compensate for poor mineralisation). IMPORTANT: ALP is normally higher in children (growing bones) — interpret in context
- **PTH (parathyroid hormone)**: ELEVATED (secondary hyperparathyroidism) — the parathyroid glands increase PTH secretion to maintain serum calcium by pulling calcium from bone. This compensatory mechanism maintains calcium at the expense of BONE HEALTH (osteoporosis)
- **X-ray**: Rickets — cupping, fraying, and widening of the metaphyses (especially wrist and knee). Osteomalacia — Looser's zones (pseudofractures), generalised osteopenia
- **DEXA scan**: For bone density assessment if osteoporosis is suspected (post-menopausal women, elderly, fractures). Available at most Indian tertiary hospitals
Differential Diagnosis
Diffuse aches, fatigue or proximal weakness are not specific for vitamin D deficiency. Consider hypothyroidism, anaemia, inflammatory myopathy, polymyalgia rheumatica, fibromyalgia, medication effects, depression and deconditioning. Bone pain or fractures require consideration of osteoporosis, osteomalacia from phosphate disorders, hyperparathyroidism, renal osteodystrophy, malignancy and infiltrative disease. A low bone mineral density result does not by itself prove vitamin D deficiency or explain pain.
Rickets or osteomalacia with a normal 25-hydroxyvitamin D level should prompt consideration of hypophosphataemic disorders, renal tubular phosphate wasting, vitamin-D-dependent rickets, renal disease and hepatic disease. Hypocalcaemia may reflect hypoparathyroidism, magnesium deficiency or acute illness. Persistently high calcium during treatment is not a sign to give more vitamin D: exclude primary hyperparathyroidism, malignancy, thyrotoxicosis, granulomatous disease and exogenous calcium or vitamin D excess. In a child, growth failure and deformity require paediatric assessment rather than empiric high-dose products. The differential should be driven by history, examination and calcium-phosphate-PTH relationships.
Management
Supplementation Regimens
**For DEFICIENCY (25(OH)D <25 nmol/L / <10 ng/mL):**
**Loading dose (to rapidly restore levels):** - Cholecalciferol (vitamin D3) 60,000 IU once WEEKLY for 8 weeks (total: 450,000 IU). This is the MOST COMMONLY USED regimen in India — sachets of cholecalciferol 60,000 IU (granules dissolved in water/milk) are widely available and affordable (₹20-40 per sachet) - Alternative: Cholecalciferol 300,000 IU as a single IM injection (calciferol injection). Used when compliance with oral therapy is a concern. Available in India. Effect lasts 3-6 months
**Maintenance dose (lifelong in many cases):** - Cholecalciferol 60,000 IU once MONTHLY (or 1,000-2,000 IU DAILY) - Maintenance is ESSENTIAL — deficiency recurs if supplementation is stopped (because the underlying causes — indoor lifestyle, dark skin, vegetarian diet — persist)
**For INSUFFICIENCY (25(OH)D 25-50 nmol/L / 10-20 ng/mL):** - Cholecalciferol 60,000 IU once weekly for 4 weeks, then monthly maintenance
**In SPECIAL POPULATIONS:** - **Pregnancy**: Cholecalciferol 1,000-2,000 IU daily throughout pregnancy. Some Indian guidelines recommend 60,000 IU monthly. Screen 25(OH)D and treat deficiency actively — maternal deficiency → neonatal deficiency → neonatal hypocalcaemia, rickets - **Breastfed infants**: 400 IU daily from birth (breast milk is a POOR source of vitamin D). Continue until the infant is on adequate dietary sources - **CKD**: May need ACTIVE vitamin D (calcitriol [Rocaltrol] 0.25-0.5 µg daily or alfacalcidol 0.25-1 µg daily) because the kidney cannot perform 1α-hydroxylation. Monitor calcium closely (risk of hypercalcaemia) - **Malabsorption**: Higher doses needed (may need IM injection or high-dose oral). Monitor levels - **Obesity**: Higher doses needed (vitamin D sequestered in fat). Some guidelines recommend 2-3× the standard dose
Calcium Co-Supplementation
- Vitamin D supplementation alone is INSUFFICIENT if dietary calcium intake is also low — which it often is in India
- Recommended calcium intake: 1,000mg/day for adults; 1,200mg/day for post-menopausal women and elderly
- DIETARY sources (preferred over supplements): Milk and dairy (200-300mg per glass of milk), curd/yoghurt, paneer, ragi (nachni — 344mg/100g — one of the richest plant sources), sesame seeds (til), almonds, green leafy vegetables (methi, spinach — but oxalates reduce absorption), sardines with bones
- SUPPLEMENTS: Calcium carbonate (cheapest, take WITH food — needs acid for absorption) or calcium citrate (take with or without food — better for patients on PPI/antacids). Typical: 500-1000mg elemental calcium daily. Shelcal, CCM, Calcimax are common Indian brands
- Do NOT over-supplement calcium (>2000mg/day) — risk of kidney stones and possibly cardiovascular events
Replacement is not a self-care licence for repeated megadoses. Recheck adherence and, when clinically indicated, 25(OH)D and calcium after a defined interval; renal disease, malabsorption, obesity, interacting medicines and persistent abnormal calcium need tailored supervision. Do not use calcitriol for uncomplicated deficiency. In pregnancy and children, use age- and pregnancy-appropriate products and doses, verify total intake from all preparations, and avoid loading regimens unless a clinician has selected them.
Prescribing Information
Cholecalciferol (Vitamin D3) [Arachitol, D-Rise, Calcirol]
- Loading: 60,000 IU/week for 8 weeks (oral sachets — most popular form in India)
- Maintenance: 60,000 IU/month OR 1,000-2,000 IU daily
- Take with a FATTY MEAL (fat-soluble — absorption is 50% higher with fat)
- Side effects: Rare at therapeutic doses. TOXICITY occurs at very high doses (>300,000 IU/month for prolonged periods): Hypercalcaemia → nausea, vomiting, confusion, renal stones, renal failure. Monitor calcium if using high doses for prolonged periods
- Cost: ₹20-40 per 60,000 IU sachet. One of the CHEAPEST medical interventions available
Calcitriol [Rocaltrol, Caltrol] — Active Vitamin D
- Dose: 0.25-0.5 µg OD-BD
- Used ONLY when 1α-hydroxylation is impaired (CKD stages 4-5, hypoparathyroidism)
- NOT for routine vitamin D deficiency (it bypasses the storage form — cannot restore 25(OH)D levels, and has a narrow therapeutic window → hypercalcaemia risk)
- Monitor serum calcium closely (weekly initially, then monthly)
- Cost: ₹100-300/month
Calcium Carbonate [Shelcal, CCM]
- Dose: 500-1000mg elemental calcium daily (in divided doses — maximum 500mg per dose for optimal absorption)
- Take WITH meals (needs gastric acid for absorption)
- Side effects: Constipation (common), bloating, flatulence. Kidney stones at excessive doses
- Cost: ₹50-150/month
When to Refer
Refer urgently for symptomatic hypocalcaemia, seizures, tetany, pathological fracture, severe proximal weakness, confusion, vomiting or suspected hypercalcaemia. Arrange specialist input for children with rickets, pregnancy with significant deficiency or hypercalcaemia, chronic kidney disease stages 4–5, nephrotic or malabsorptive disease, granulomatous disease, lymphoma, recurrent renal stones or unexplained abnormal calcium, phosphate or PTH. Endocrinology or metabolic bone review is appropriate when the diagnosis is uncertain, replacement fails despite verified adherence, or biochemical abnormalities persist. Nephrology should guide activated vitamin-D therapy in advanced kidney disease. A referral should include the actual products and total doses taken, 25(OH)D assay and units, calcium with albumin or ionised calcium, phosphate, ALP, PTH, creatinine/eGFR and relevant imaging. Do not delay emergency care while waiting for outpatient review.
Red Flags
- **Hypocalcaemic seizures** (especially in neonates and infants): A medical emergency. IV calcium gluconate 10% — 0.5-1 mL/kg SLOW IV over 5-10 minutes with cardiac monitoring. Then oral calcium + vitamin D supplementation. ALWAYS check maternal vitamin D status
- **Severe hypocalcaemia** (corrected calcium <1.9 mmol/L / <7.6 mg/dL): Symptoms: tetany (carpopedal spasm), laryngospasm (stridor), prolonged QTc → risk of torsades de pointes. IV calcium gluconate urgently. Monitor ECG
- **Pathological fracture with minimal trauma**: Osteomalacia or osteoporosis. X-ray → DEXA → vitamin D, calcium, PTH, ALP. Assess falls risk. Start supplementation + consider bisphosphonate if osteoporotic (AFTER correcting vitamin D — bisphosphonates are less effective in vitamin D deficiency)
- **Vitamin D level NOT improving despite supplementation**: Consider: Non-compliance (most common), malabsorption (coeliac disease — check tTG antibodies, IBD), medications increasing vitamin D metabolism (phenytoin, rifampicin), incorrect product (some 'vitamin D' supplements contain vitamin D2 (ergocalciferol) which is less effective than D3 (cholecalciferol) at raising 25(OH)D), obesity (higher doses needed)
- **Very high 25(OH)D** (>375 nmol/L / >150 ng/mL): Vitamin D TOXICITY — rare but dangerous. Usually from excessive supplementation (not from sunlight — skin synthesis self-regulates). Causes HYPERCALCAEMIA: nausea, vomiting, confusion, polyuria, polydipsia, renal stones, renal failure. Stop all vitamin D and calcium. IV saline. If severe: IV bisphosphonate (zoledronic acid), consider glucocorticoids
- **Rickets with NORMAL vitamin D**: Consider: Vitamin D-resistant rickets (X-linked hypophosphataemia — low phosphate, normal calcium), Vitamin D-dependent rickets type 1 (defective 1α-hydroxylase — needs calcitriol) or type 2 (vitamin D receptor defect — alopecia is a clue). Refer to paediatric endocrinology
Indian Clinical Context
Vitamin D deficiency in India is paradoxical and pervasive:
The Indian paradox: India receives abundant sunlight year-round, yet 70-90% of Indians are vitamin D deficient. This reflects the complex interaction of skin pigmentation (higher melanin), indoor lifestyle (urbanisation), air pollution (UVB filtering), clothing practices, vegetarian diet (poor dietary sources), and absence of national food fortification.
Clinical implications: Vitamin D deficiency contributes to India's enormous burden of bone disease: osteoporosis (estimated 50 million Indians), rickets (still seen in paediatric practice despite abundant sunlight), and osteomalacia (frequently misdiagnosed as 'body pains' or 'weakness'). It also worsens the outcomes of TB (vitamin D modulates anti-mycobacterial immunity — deficiency impairs macrophage killing of M. tuberculosis), diabetes (vitamin D deficiency is associated with insulin resistance — though supplementation trials show mixed results), and pre-eclampsia.
Practical supplementation: The 60,000 IU weekly sachet regimen is ideal for India — cheap (₹20-40 per dose), convenient (once weekly during loading, then monthly), well-tolerated, and widely available. However, COMPLIANCE IS THE MAIN CHALLENGE. Many patients take the loading course, feel better, and then stop — leading to recurrence within months. Patient education about the need for lifelong maintenance supplementation is essential.
Sunlight exposure recommendations: 10-30 minutes of direct sunlight (without sunscreen) on face, arms, and legs, 3-5 times per week, between 10 AM and 3 PM (when UVB is strongest). However, this is INSUFFICIENT for many Indians due to skin pigmentation, air pollution, and practical constraints (office workers, women in purdah, children in school during peak UV hours). Supplementation is therefore necessary for most Indians — relying on sunlight alone is not a realistic strategy.
Testing: Serum 25(OH)D is widely available in India (₹800-2000). However, there is debate about whether mass screening is cost-effective. The Endocrine Society of India recommends targeted testing in high-risk groups rather than universal screening. Given the very high prevalence (~80%), some clinicians argue that empirical supplementation of ALL Indians is more cost-effective than testing.
NMC Competency Mapping
This guide supports NMC competency-based learning in internal medicine, paediatrics and pharmacology: taking a risk- and symptom-led history; examining for rickets, osteomalacia, proximal weakness and fracture; interpreting 25-hydroxyvitamin D with calcium-phosphate-PTH relationships; and constructing a safe, patient-centred plan. Learners should explain that a laboratory threshold is not a diagnosis in isolation, distinguish nutritional deficiency from renal, hepatic, malabsorptive and phosphate disorders, and identify toxicity. Safe prescribing includes checking duplicate products, pregnancy, age, kidney function, stones, granulomatous disease and interacting medicines, then documenting a review and monitoring plan. Students must recognise that high-dose replacement, calcitriol and parenteral products require supervision and that emergency hypocalcaemia or hypercalcaemia needs escalation. This educational mapping does not authorise independent prescribing. Safe learning also requires checking the current Indian product label and local policy before applying a regimen.
Key Exam Pearls for NEET PG
- Vitamin D metabolism: Skin (UVB → D3) → Liver (25-hydroxylation → 25(OH)D — STORAGE form, measured clinically) → Kidney (1α-hydroxylation → 1,25(OH)₂D — ACTIVE form, regulated by PTH)
- Deficiency: <25 nmol/L (<10 ng/mL). Insufficiency: 25-50 nmol/L (10-20 ng/mL). Sufficient: >50 nmol/L (>20 ng/mL). Measure 25(OH)D, NOT 1,25(OH)₂D
- Rickets (children): Craniotabes, frontal bossing, rachitic rosary, Harrison's sulcus, bowed legs (genu varum), wrist widening, delayed walking. X-ray: cupping, fraying, widening of metaphyses
- Osteomalacia (adults): Bone pain (diffuse, bilateral), proximal myopathy, fractures. X-ray: Looser's zones (pseudofractures — PATHOGNOMONIC). ALP raised, calcium low/normal, phosphate low, PTH raised
- SECONDARY HYPERPARATHYROIDISM: Low vitamin D → low calcium → HIGH PTH → bone resorption (to maintain calcium) → osteoporosis
- India: 70-90% of Indians are vitamin D DEFICIENT despite tropical sunlight. Causes: dark skin (melanin), indoor lifestyle, air pollution, clothing, vegetarian diet, no national fortification
- Treatment: Cholecalciferol 60,000 IU/week × 8 weeks (loading), then 60,000 IU/month (maintenance). Take with fatty meal
- CKD patients: Cannot perform 1α-hydroxylation → need CALCITRIOL (active vitamin D), not cholecalciferol
- Vitamin D TOXICITY: Hypercalcaemia (nausea, confusion, renal stones). Cannot occur from excessive sunlight (skin self-regulates). Only from excessive supplementation
- Breastfed infants: Need 400 IU/day from birth (breast milk is LOW in vitamin D)
- Drugs that increase vitamin D metabolism: Phenytoin, carbamazepine, phenobarbitone, rifampicin (CYP3A4 induction)
- Ragi (nachni/finger millet): 344mg calcium/100g — one of the richest plant sources. Highly relevant for Indian diet counselling
Frequently Asked Questions
Why are so many Indians vitamin D deficient despite living in a sunny country?
This is indeed paradoxical, and the answer lies in the interaction of multiple factors: (1) SKIN PIGMENTATION: The melanin in darker skin acts as a natural sunscreen — it BLOCKS UVB radiation, which is the specific wavelength needed for vitamin D synthesis. An Indian with dark skin needs 3-5 times MORE sun exposure than a fair-skinned European to produce the same amount of vitamin D. While melanin protected our ancestors from skin cancer and folate degradation in equatorial Africa, it reduces vitamin D synthesis. (2) INDOOR LIFESTYLE: Modern urbanisation has moved Indians indoors. Office workers, students, homemakers, and increasingly children spend 80-90% of daylight hours inside. Glass windows do NOT transmit UVB — so sitting near a window does not help. High-rise apartments, covered walkways, and malls further reduce exposure. (3) AIR POLLUTION: India has some of the world's worst air quality. Particulate matter (PM2.5 and PM10) and ozone in polluted air FILTER UVB radiation before it reaches the skin. Studies in Delhi show that vitamin D synthesis is reduced by up to 50% during high-pollution months (October-February). (4) CLOTHING: Cultural practices of covering most skin (especially among women) dramatically reduce the surface area available for vitamin D synthesis. (5) VEGETARIAN DIET: The richest dietary sources of vitamin D are oily fish and fish liver oils — which a large proportion of vegetarian Indians don't consume. There is no mandatory vitamin D food fortification programme in India. (6) LATITUDE AND SEASON: While most of India is tropical, the northern regions (Delhi, UP, Punjab) have significantly reduced UVB during winter months (November-February), compounding the problem. BOTTOM LINE: For most Indians, dietary changes and sunlight alone are INSUFFICIENT. Supplementation is the most practical solution.
How much sun exposure do I need for adequate vitamin D?
The amount of sun exposure needed depends on your skin colour, latitude, time of day, season, and clothing: GENERAL RECOMMENDATION: 10-30 minutes of direct sunlight on face, forearms, and lower legs (without sunscreen), 3-5 times per week, between 10 AM and 3 PM (when UVB is strongest). ADJUSTMENTS FOR INDIAN PATIENTS: (1) DARKER SKIN NEEDS MORE: If you have very dark skin (Fitzpatrick type V-VI, common in South and East India), you may need the UPPER end of this range (20-30 minutes) or even more. Lighter-skinned North Indians may need 10-15 minutes. (2) LATITUDE MATTERS: In North India (Delhi, Lucknow, Jaipur), UVB is minimal from November to February — even prolonged sun exposure during winter won't produce much vitamin D. Supplementation is essential during these months. South India receives UVB year-round but air pollution can still reduce it. (3) AIR POLLUTION: In highly polluted cities (Delhi, Mumbai, Kolkata), UVB reaching the ground is reduced — even midday sun may be insufficient. (4) TIME OF DAY: Morning sun (before 10 AM) and late afternoon sun (after 3 PM) contain very little UVB — the 'gentle morning walk sun' that many Indians believe is sufficient does NOT produce meaningful vitamin D. Peak UVB is between 10 AM and 3 PM. (5) AREA OF SKIN: More skin exposed = more vitamin D. Exposing just the face is insufficient. Forearms and legs should also be exposed. IMPORTANT CAVEATS: (a) There is a CEILING to daily vitamin D production from sunlight — beyond about 20-30 minutes, no additional vitamin D is produced. Prolonged sun exposure does NOT produce more vitamin D but DOES increase skin cancer risk. (b) Sunscreen with SPF 30 reduces vitamin D synthesis by 95-99%. (c) UVB cannot penetrate glass — sun through a window does NOT count. PRACTICAL ADVICE: For most urban Indians, sun exposure alone is NOT a reliable source of vitamin D. Supplementation (60,000 IU monthly) is safer, more reliable, and very cheap.
Can you take too much vitamin D?
YES — vitamin D toxicity (hypervitaminosis D) is possible, though it is RARE and requires prolonged consumption of very high doses. Key points: (1) HOW MUCH IS TOO MUCH: The tolerable upper intake level (UL) is 4,000 IU/day for adults (some guidelines allow up to 10,000 IU/day short-term). Toxicity typically occurs at doses >50,000 IU/day for several months, or with 25(OH)D levels >375 nmol/L (>150 ng/mL). The standard Indian regimen (60,000 IU weekly × 8 weeks, then monthly) is SAFE — toxicity is not a concern at this dose. (2) CAN'T OVERDOSE FROM SUNLIGHT: Your skin has a built-in safety mechanism — once enough vitamin D3 is produced, further UVB exposure converts it to inactive metabolites. You CANNOT get vitamin D toxicity from sun exposure alone. (3) SYMPTOMS OF TOXICITY: Caused by HYPERCALCAEMIA (excess vitamin D increases calcium absorption): Nausea, vomiting, poor appetite, constipation, weakness, confusion, kidney stones, polyuria (excessive urination), and in severe cases, kidney failure, cardiac arrhythmias, and calcification of soft tissues. (4) WHO IS AT RISK: People taking megadoses (self-prescribing very high doses from the internet), patients with granulomatous diseases (sarcoidosis, TB — granulomas produce calcitriol independently, so vitamin D supplementation can cause hypercalcaemia more easily), Williams syndrome (genetic condition with increased sensitivity to vitamin D). (5) MONITORING: For routine supplementation (60,000 IU monthly), NO routine monitoring of 25(OH)D or calcium is needed in otherwise healthy patients. Check 25(OH)D and calcium if using high doses (>4,000 IU/day), if the patient has CKD, sarcoidosis, or hyperparathyroidism, or if symptoms of hypercalcaemia develop.
Should all Indians take vitamin D supplements?
This is a genuinely debated question in Indian medicine, and the answer depends on whether you prioritise individual testing or population-level supplementation: THE CASE FOR UNIVERSAL SUPPLEMENTATION: Given that 70-90% of Indians are vitamin D deficient, and the underlying causes (dark skin, indoor lifestyle, air pollution, vegetarian diet, no fortification) affect virtually the entire population, many clinicians and public health experts argue that it is more cost-effective to recommend supplementation for ALL Indians rather than testing each individual. The supplement (cholecalciferol 60,000 IU monthly) costs ₹20-40 per month — far cheaper than the blood test (₹800-2000). For the 10-30% who are NOT deficient, the supplementation dose is well within the safe range and will not cause toxicity. This is essentially the approach used in the UK (where 400 IU daily is recommended for everyone during winter) and in many guidelines for pregnant women and infants (supplement without testing). THE CASE FOR TARGETED TESTING AND SUPPLEMENTATION: The Endocrine Society of India recommends testing in HIGH-RISK GROUPS (pregnant women, post-menopausal women, elderly, patients with bone disease/fractures, CKD, malabsorption, on anti-epileptic drugs/steroids, and those with symptoms like bone pain and muscle weakness) and supplementing based on results. This avoids unnecessary supplementation in the minority who are sufficient and allows dose adjustment for those who are severely deficient. PRACTICAL RECOMMENDATION: For most Indian adults, taking cholecalciferol 60,000 IU monthly as maintenance supplementation is safe, effective, and affordable — regardless of whether they have been tested. This is particularly true for people who: spend most of their time indoors, have dark skin, are vegetarian, live in polluted cities, or are pregnant/breastfeeding. Test if: you have symptoms (bone pain, muscle weakness, fatigue), risk factors for severe deficiency, or conditions that might affect vitamin D metabolism.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic